Literature DB >> 11206374

Computational modeling of a binding conformation of the intermediate L-histidinal to histidinol dehydrogenase.

K Gohda1, D Ohta, G Iwasaki, P Ertl, O Jacob.   

Abstract

Histidinol dehydrogenase (HDH) is one of the enzymes involved in the L-histidine biosynthesis pathway. HDH is a dimer that contains one Zn2+ ion in each identical subunit. In this study, we predicted a possible binding conformation of the intermediate L-histidinal, which is experimentally not known, using a computational modeling method and three potent HDH inhibitors whose structures are similar to that of L-histidinal. At first, a set of the most probable active conformations of the potent inhibitors was determined using two different pharmacophore mapping techniques, the active analogue approach and the distance comparison method. From the most probable active conformations of the three potent inhibitors, the common parts of the L-histidinal structure were extracted and refined by energy minimization to obtain the binding conformation of L-histidinal. This predicted conformation of L-histidinal agrees with an experimentally determined conformation of L-histidine in a single crystal, suggesting that it is an experimentally acceptable conformation. The capability in this conformation to coordinate a Zn2+ ion was examined by comparing the spatial relative geometry of its functional groups with those of ligands that coordinate with a Zn2+ ion in Zn proteins of the Protein Data Bank. This comparison supported our predicted conformation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11206374     DOI: 10.1021/ci000332n

Source DB:  PubMed          Journal:  J Chem Inf Comput Sci        ISSN: 0095-2338


  3 in total

1.  Mechanism of action and NAD+-binding mode revealed by the crystal structure of L-histidinol dehydrogenase.

Authors:  João A R G Barbosa; J Sivaraman; Yunge Li; Robert Larocque; Allan Matte; Joseph D Schrag; Miroslaw Cygler
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-12       Impact factor: 11.205

2.  Targeting of the Brucella suis virulence factor histidinol dehydrogenase by histidinol analogues results in inhibition of intramacrophagic multiplication of the pathogen.

Authors:  Pascale Joseph; Marie-Rose Abdo; Rose-Anne Boigegrain; Jean-Louis Montero; Jean-Yves Winum; Stephan Köhler
Journal:  Antimicrob Agents Chemother       Date:  2007-08-13       Impact factor: 5.191

3.  Structures of Medicago truncatula L-Histidinol Dehydrogenase Show Rearrangements Required for NAD+ Binding and the Cofactor Positioned to Accept a Hydride.

Authors:  Milosz Ruszkowski; Zbigniew Dauter
Journal:  Sci Rep       Date:  2017-09-05       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.